Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology is discovered. Improved health care, nutrition and preventive medicine in the last few decades have all helped in increasing the life expectancy WW. However, this has not translated into any reduction in the incidence or prevalence of chronic or critical illnesses! On the contrary the incidence of chronic diseases like diabetes, obesity, arthritis etc. as well as cancer and the maladies associated with aging (dementia, Alzheimer’s etc.) are on the rise!. Consequently the pharma industry continues to grow and is projected to achieve sales in excess of trillion dollar mark by 2020 By the next decade, one field which is poised to bring a paradigm change in the way diseases are treated is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines.

MORE INFORMATION: http://www.gosreports.com/regenerative-medicine-and-stem-cell-based-cell-therapies-drugs-of-the-future-offering-hope-for-cure/

EXECUTIVE SUMMARY• INTRODUCTION• Tough Choice- “Autologous vs. Allogenic “” Therapies• REGULATORY GUIDELINES• Marketed Cell based/Stem Cell Products• Progress and Challenges• Progress in Specific Therapy Areas• SELECT UPCOMING MILESTONES IN REGENERATIVE MEDICINE/STEMCELL FOCUSED COMPANIES (2015-16)• Appendix

MORE INFORMATION: http://www.gosreports.com/regenerative-medicine-and-stem-cell-based-cell-therapies-drugs-of-the-future-offering-hope-for-cure/

------------------